Immunology
In 1908, Russian biologist Ilya Mechnikov received the Nobel Prize for his work on immunity alongside Paul Ehrlich. Before that award, Mechnikov performed a simple experiment with starfish larvae. He pinned small thorns into their soft bodies and watched closely what happened next. Unusual cells gathered around the sharp points of wood. This active response showed how the body tried to maintain its integrity against foreign objects. It was this observation that led him to name phagocytosis as the process where the body defends itself. The phenomenon proved that living organisms possess an internal mechanism to fight invaders. His work laid the foundation for modern immunology as a distinct scientific field.
The earliest written mention of immunity dates back to the plague of Athens in 430 BCE. Historian Thucydides noted that people who had recovered from a previous bout of disease could nurse the sick without contracting the illness again. These survivors did not fall ill a second time after exposure. Many other ancient societies have references to this phenomenon, but it remained anecdotal for centuries. It was not until the 19th and 20th centuries before the concept developed into scientific theory. Early physicians characterized organs like the thymus and bone marrow as essential components long before they understood their function. The study of these systems eventually tied together epidemiology and medicine to explain human survival during outbreaks.
The end of the 19th century saw a fierce battle between cellular and humoral theories of immunity. Elie Metchnikoff represented the cellular theory which claimed phagocytes were responsible for immune responses. In contrast, Robert Koch and Emil von Behring held the humoral theory stating active agents were soluble molecules found in humors rather than cells. Paul Ehrlich accustomed mice to poisonous ricin by feeding them small but increasing dosages over time. He observed that they became ricin-proof after a few days and maintained protection for several months. This interpretation defined immunization as an abrupt initiation followed by lasting existence. The debate continued until Macfarlane Burnet formulated the clonal selection theory in the mid-1950s based on suggestions from Niels Jerne.
Clinical disorders fall into two broad categories involving failure or aberrant action of the system. Immunodeficiency occurs when parts of the immune system fail to provide an adequate response. Examples include chronic granulomatous disease and primary immune diseases affecting individuals globally. Autoimmunity happens when the immune system attacks its own host body instead of invaders. Conditions like systemic lupus erythematosus and rheumatoid arthritis exemplify this internal conflict. Hashimoto's thyroiditis and myasthenia gravis also represent autoimmune failures where the body turns against itself. Other disorders include hypersensitivities such as asthma that respond inappropriately to harmless compounds. The most well-known disease affecting the system itself is AIDS characterized by suppression of CD4 helper T cells.
The specificity of the bond between antibody and antigen has made antibodies excellent tools for detection. Scientists conjugate these proteins with isotopic labels, fluorescent markers, or color-forming enzymes to identify substances. This technique allows for the detection of various antigens through diagnostic testing. However, similarity between some antigens can lead to false positives and other errors in tests. Antibodies may cross-react with antigens that are not exact matches causing confusion in results. Despite these limitations, the method remains central to modern medicine for identifying pathogens and substances within patients. It enables the study of physiological reactions characteristic of specific immune states during illness.
Immunotherapy uses immune system components or antigens to treat a disease or disorder directly. Doctors commonly apply this approach to manage allergies and certain cancers like leukemia or lymphoma. Patients with HIV who are immunosuppressed often receive treatments involving regulating factors such as IL-2 or IFN-alpha. Transplant rejection also requires intervention where the immune system attempts to destroy allografts. Clinical immunologists study ways to prevent these destructive responses during organ transplantation procedures. The field explores how inflammation observed in many types of cancers can be harnessed against tumor growth. Researchers investigate interactions between cancer cells and the immune system to find new therapies.
Up Next
Common questions
When did Ilya Mechnikov receive the Nobel Prize for his work on immunity?
Ilya Mechnikov received the Nobel Prize in 1908 for his work on immunity alongside Paul Ehrlich. This award recognized his earlier experiments with starfish larvae that led to the discovery of phagocytosis.
What is the earliest written mention of immunity and when did it occur?
The earliest written mention of immunity dates back to the plague of Athens in 430 BCE. Historian Thucydides recorded that survivors who recovered from the disease could nurse others without falling ill again.
Who formulated the clonal selection theory in immunology and when was it created?
Macfarlane Burnet formulated the clonal selection theory in the mid-1950s based on suggestions from Niels Jerne. This theory resolved the long-standing debate between cellular and humoral theories of immunity.
Which diseases are classified as examples of autoimmune disorders in clinical immunology?
Autoimmune disorders include systemic lupus erythematosus, rheumatoid arthritis, Hashimoto's thyroiditis, and myasthenia gravis. These conditions occur when the immune system attacks its own host body instead of foreign invaders.
How do antibodies function as tools for detection in modern medicine?
Scientists conjugate antibodies with isotopic labels, fluorescent markers, or color-forming enzymes to identify substances through diagnostic testing. This method allows for the detection of various antigens despite potential errors caused by cross-reactivity.